Medilink NOE News Summer 2020 Summer 2020 - Page 7
LEEDS GENERAL INFIRMARY
IS PLANNING TO EXPAND ITS
FACILITIES AND SERVICES
Last October, Leeds Teaching Hospitals NHS Trust
revealed exciting proposals for a brand-new development
to transform Leeds General Infirmary (LGI).
Plans for two state-of-the-art hospital buildings, including
a dedicated Children’s Hospital on the Leeds General
Infirmary site have been submitted to Leeds City Council.
They are part of an ambitious, long-term vision for the LGI
called Hospitals of the Future, which aims to revolutionise
health services for patients in Leeds and the wider region.
There will be a new theatre suite dedicated to day
procedures, endoscopy and radiology as well as a
pharmacy to support a central Outpatients department.
The extension of health services for adults will be the focus
of the first hospital building, which will be joined to the
LGI’s Jubilee Wing.
Greater critical care capacity will enable LGI to expand its
highly specialist services, like major trauma or cardiac
care. These services benefit people in the community and
The second hospital building will be a new Leeds Children’s
Hospital. Bringing together services and staff from the
existing Children’s hospital, it will deliver healthcare
for children and young people in a purpose built facility
dedicated to their specific needs.
The new hospital buildings will be designed to support
advanced treatment and care based on the latest
technologies and innovation. For patients, this will
mean more efficient, individual healthcare in modern
comfortable surroundings. Flexible spaces will be used
to adapt and respond to changing patient needs over the
lifetime of the hospital.
Julian Hartley, Chief Executive, Leeds Teaching Hospitals
said: “This is a really exciting development for our hospitals
that will be a huge step forward in the way we provide
healthcare for patients in Leeds and the wider region.
“By designing hospital buildings from the ground up, we’ll
be able to embrace new technologies and innovation to
deliver modern, efficient health services that are tailored to
our patients’ needs, not just now but in the future.”
To find out more about the Leeds General Infirmary’s
vision and plans for the future development, please visit
Regulation is the number one issue facing Lifescience
businesses now that the worst of the Covid-19 crisis has
hopefully subsided. The additional requirements of the
impending new European Medical Device Regulation (May
2021) and the new Invitro Diagnostic Regulation (May
2022), the major under capacity in our notifi ed bodies
and Brexit combine to create one of the biggest threats
to Lifescience businesses in a generation – not just in the
North but nationally.
Taking just one of these factors, SMEs are particularly
unprepared for the new MDR as evidenced in a recent
national Medilink UK / ISO Life Science report* with
transitioning to MDR being costly and complex, with MDR
requiring signifi cantly more in terms of clinical evidence,
risk assessments, post-market surveillance, supply chain
obligations and new IT systems (for the Unique Device
Identifi cation (UDI) system and the new EU Eudamed
database), not to mention new packaging and labelling.
Medilink North of England are in the process of rolling
out a new Medilink Regulatory service to support MDR
implementation - this brings together Medilink’s internal
expertise e.g. regulatory gap analysis and authoring
of clinical evaluation reports, with that of a network of
accredited regulatory consultants, but it is clear that direct
government intervention will be required if we are not to
lose key indigenous Lifescience companies. Of course, the
terms on which we leave Brexit will determine whether
there will be yet another complex recertifi cation process
required which would again have a disproportionately
negative impact on SMEs.
Whether you are seeking a specialist to undertake
a compliance gap analysis, a regulatory consultant
to assist with MDD/MDR or IVD/IVDR transitioning,
or someone to write ‘Clinical Evaluation Reports’ or
‘Biological Evaluation Reports’, please contact us at
INVITED TO HELP SHAPE
THE WORKFORCE OF
Employers and experienced practitioners from across the
health and science sectors are being invited to participate
in an exciting programme to help shape a new suite of
government-commissioned technical qualifications.
Due to launch in September 2020, T levels are a highquality,
work-focussed alternative to A levels for young
people aged 16-18 once they’ve completed their GCSEs. The
programmes consist of theory-based technical learning
combined with practical activities, English, maths and
digital content, plus an extended work placement. They are
designed to bridge the gap between the classroom and the
workplace, supporting progress into higher or degree level
apprenticeships, higher education, or employment.
Medilink member and National Awarding Organisation,
NCFE, is working with Government to develop T level
qualifications for: health; healthcare science; and,
science. Employer input to the development of these new
qualifications is vital in ensuring that T levels reflect the
needs of the occupations they’re designed to serve. To
that end, NCFE is now looking to build on its network of
leading experts and employers from across the digital, and
health and science sectors to gain additional support in the
development of these qualifications.
This represents a great opportunity for employers and
professionals to help influence the qualifications that
will create the next generation of skilled workers in the
health and science sectors. Contributors don’t need
to be education experts. NCFE are simply looking for
experienced practitioners in relevant health and science
occupations to reflect on the knowledge and skills they
need in their work to help create qualifications that set
learners up for success.
Input can be provided remotely and at whatever time of
day, night, week or weekend suits colleagues best. Those
interested in supporting this work are invited to contact
NCFE T Level Partnership lead, Zac Aldridge (zacaldridge@
ncfe.org.uk / tel: 07792 298 383).
For more information, visit: www.ncfe.org.uk/t-levels/tlevels-for-employers.
THE IMPACT AND
LEGACY OF COVID-19
- A VIEW FROM CHRIS KENNELLY, CEO CIEVERT
Coronavirus will have a
legacy that is broader and
farther reaching than the
impact of lockdown.
How we work, shop,
socialise, communicate and
more has all changed, and
is unlikely to return to BC
(Before Covid). Healthcare
is no different. In fact, the
change to how we access
healthcare may be the greatest legacy of coronavirus.
For many, healthcare is passive – it’s something to receive or
endure when you’re unwell: a trip to the GP, a tablet to make
you better… Coronavirus has reminded us that effective
healthcare is two-way. It’s taught us that prevention is
preferable and that what we do as individuals has a huge
influence on our continued wellbeing.
Lockdown has accelerated the use of technology in
healthcare, but the focus of this technology has mainly
been about replacing like for like – a consultation via video
call is still a consultation. The long-term legacy will be
an increasing acceptance of technology. Technology will
increasingly, be expected by patients – it is this that will
deliver lasting change and improvement.
At Cievert we’re already using technology to track patient
symptoms and outcomes in clinical areas as diverse as
cancer, gastroenterology and renal. We identify clinical need
when it presents and we automatically alert clinical teams
when required. Identifying clinical need outside of traditional
healthcare immediately provides opportunity for healthcare to
be delivered in innovative and more effective ways.
Technology-led healthcare may not be for everyone, but taking
a day off work for a hospital appointment isn’t for everyone
A legacy of Coronavirus will be an increased willingness from
both doctors and their patients to broaden how healthcare is
delivered, and embracing technology will be at the centre of
this approach. And that must be a good thing.